AstraZeneca (AZ) is in a period of strong growth and our employees have a united purpose to make a difference to patients around the world who need both our medicines and the ongoing developments from our science. In this journey AZ must continue to work across borders and with partners and new colleagues in a fast and seamless way. The ambition, size and complexity of the organisation, coupled with the opportunities afforded by new technology, has led the Board to approve an Enterprise transformation programme (Axial) providing the opportunity for AZ to transform how it operates to support our...